USV plans divestment/public float to fund biotech projectIllustrative image – not actual.

USV is planning strategic divestment or public float to raise Rs.200 crore for its proposed plant at Turbhe near Mumbai. The proposed unit at Turbhe would produce recombinant proteins.

 

Initially, the company would set up a pilot project for the production of recombinant proteins. This would entail an investment of around Rs.20 crore, which would be raised internally.

 

Production on a large scale would commence, depending upon the success of the pilot plant.

← All latest storiesBack to top →